Trial of Brigatinib After Treatment With Next-Generation ALK Inhibitors
Clinical trial NCT02706626 · TERMINATED
Trial details
- NCT number
- NCT02706626
- Sponsor
- Criterium, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-09
- Primary completion
- 2020-10-08
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.